Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.6530
Abstract: Key Points Question At a single time point without confirmatory testing, what is the prevalence of antiphospholipid antibodies (aPL), and are they associated with future atherosclerotic cardiovascular disease (ASCVD) risk? Findings In this population-based cohort… read more here.
Keywords: antibodies association; incident cardiovascular; antiphospholipid antibodies; prevalence ... See more keywords
THE PREVALENCE OF ANTIPHOSPHOLIPID SYNDROME IN WOMEN AFTER PREECLAMPSIA
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000570752.59356.86
Abstract: Objective:Preeclampsia (PE) is a multisystem progressive disorder that affects 2–8% of all pregnancies. Severe and early PE ( read more here.
Keywords: syndrome women; antiphospholipid syndrome; women preeclampsia; prevalence ... See more keywords
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low‐risk for chromosomal abnormalities
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15053
Abstract: Antiphospholipid antibodies (aPL) are known to increase the risk of obstetrical complications. However, aPL significance and prevalence in women with late‐onset pregnancy complications (LO‐PC) need further clarification. read more here.
Keywords: risk; pregnancy complications; women late; prevalence antiphospholipid ... See more keywords